[ORGANIZATION]
AtaiBeckley
Featured in 3 tracked stories · first seen
Situations
US psychedelic therapy regulatory and research developments
5 clusters · 12 sources · last updated
Latest: FDA holds hearing on regulatory future of psychedelic therapies
The U.S. Food and Drug Administration (FDA) is working to develop a new framework to accelerate patient access to psychedelic medicines, such as psilocybin and DMT, to address the national mental health crisis. During a
Eli Lilly therapeutic pipeline expansion
2 clusters · 3 sources · last updated
Latest: Eli Lilly expands research in dermatology and psychedelics
Eli Lilly has been pursuing strategic expansions into new therapeutic fields, specifically mental health, immunology, and dermatology. In September 2026, the company completed its acquisition of AtaiBeckley, a biopharmac